Page last updated: 2024-08-23

pyrrolidine and Eosinophilia, Pulmonary

pyrrolidine has been researched along with Eosinophilia, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amadei, F; Amari, G; Armani, E; Bagnacani, V; Battipaglia, L; Capacchi, S; Capaldi, C; Carnini, C; Caruso, P; Carzaniga, L; Catinella, S; Cenacchi, V; Civelli, M; De Fanti, R; Delcanale, M; Facchinetti, F; Ghidini, E; Marchini, G; Moretto, N; Pappani, A; Patacchini, R; Puccini, P; Rizzi, A; Villetti, G; Volta, R	1

Other Studies

1 other study(ies) available for pyrrolidine and Eosinophilia, Pulmonary

Article	Year
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases. Journal of medicinal chemistry, 2017, 12-28, Volume: 60, Issue:24 Topics: Administration, Inhalation; Animals; Binding Sites; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Stability; Humans; Male; Phosphodiesterase 4 Inhibitors; Pulmonary Eosinophilia; Pyrrolidines; Rats, Inbred BN; Respiratory Tract Diseases; Structure-Activity Relationship; Thiazoles	2017

Article

Year

Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.

Journal of medicinal chemistry, 2017, 12-28, Volume: 60, Issue:24

Topics: Administration, Inhalation; Animals; Binding Sites; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Stability; Humans; Male; Phosphodiesterase 4 Inhibitors; Pulmonary Eosinophilia; Pyrrolidines; Rats, Inbred BN; Respiratory Tract Diseases; Structure-Activity Relationship; Thiazoles

2017